Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons

Metformin (Met) is a first-line drug for type 2 diabetes mellitus (T2DM). Numerous studies have shown that Met exerts beneficial effects on a variety of neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). However, it is still largely un...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen-Bing, Chen, Jiang, Liu, Zi-Yang, Luo, Bin, Zhou, Tian, Fei, Er-Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601223/
https://www.ncbi.nlm.nih.gov/pubmed/33020379
http://dx.doi.org/10.3390/brainsci10100706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601223/
https://www.ncbi.nlm.nih.gov/pubmed/33020379
http://dx.doi.org/10.3390/brainsci10100706

Ejemplares similares